Main Article Content
It has been projected that ferritin and iron yoke in homozygous thalassemic children is coupled with the enhanced free radical formation and blemished in antioxidative defense coordination. Aim: The purpose of the current study was to analyze the consequence of serum iron, erythrocyte catalase, and erythrocyte superoxide dismutase (ESOD) in patients with beta-thalassemia major. Method: 60 beta-thalassemia major patients were studied before and after supplementation of A – Z antioxidants for 20 weeks, and status were compared with 60 age and sex-matched healthy normal. Serum Iron estimation was carried out by Ramsay’s Dipyridyl Method. Estimation of erythrocyte superoxide dismutase was done by Kajari Das Method. The levels of Catalase concentration in erythrocytes were analyzed by the Goth method. All the objectives mentioned above were run by using a UV visible Spectrophotometer (Systronix). Results: A marked enhancement was seen in the intensity of serum iron, and superoxide dismutase (p<0.001) with parallel decline was observed in the level of erythrocyte catalase (p<0.001) in homozygous thalassemia patients when compared with healthy subjects. After 20 weeks of regular supplementation of antioxidants A-Z syrup, which consists of multimineral multivitamins, the concentration of catalase was increased whereas iron and ESOD (p<0.001) were reduced significantly when compared with normal and baselines thalassemic patients. Conclusion: Due to multiple blood transfusions, beta-thalassemia major children are at advanced risk due to secondary iron surplus and intense oxidative stress. Such kind of circumstances may be handled with supplementation of antioxidants A-Z syrup with their regular treatment.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
The submitted papers are assumed to contain no proprietary material unprotected by patent or patent application; responsibility for technical content and for protection of proprietary material rests solely with the author(s) and their organizations and is not the responsibility of the journal. The main (first/corresponding) author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the responsibility of the author to obtain all necessary copyright release permissions for the use of any copyrighted materials in the manuscript prior to the submission.
What are my rights as an author?
It is important to check the policy for the journal to which you are submitting or publishing to establish your rights as
Author. Journal's standard policies allow the following re-use rights:
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to obtain publishing rights without restrictions.
- You may do whatever you wish with the version of the article you submitted to the journal.
- Once the article has been accepted for publication, you may post the accepted version of the article on your own personal website, your department's website or the repository of your institution without any restrictions.
- You may not post the accepted version of the article in any repository other than those listed above (i.e. you may not deposit in the repository of another institution or a subject-matter repository) until 12 months after publication of the article in the journal.
- You may use the published article for your own teaching needs or to supply on an individual basis to research colleagues, provided that such supply is not for commercial purposes.
Nancy F, Olivieri MD. The β- thalassemias. The New England J. of Medicine 1999;341(2):99-108
Naveen T. Prevention of Thalassemia in India. Indian Pediatrics 2007;44:647-8
Nandita Das, Chowdhury TD, Chattopadhyay AD. Attenuation of oxidation stress induced changes in thalassemic erythrocytes by Vitamin E. Pol J Pharmocol 2004; 56:85-96
Kuldeep KG, Amit M, Archana T. Production of reactive oxygen species, Its effects, drugs and plant extract used as an antioxidant, chelator on thalassemic patients: A Review. International J of Pharma Sciences and Research 2011;2(9):2278-85
Asmaa Nafady, Sanaa Shaker Ali, Hosney Mohammed Ahmed EI Masry, Khaled Abdel Baseer et al. Oxidative stress in pediatric patients with β- thalassemia major. Egyptian Journal of Haematology 2017;42(3):123-7
Elijah K Golgberg, Sushrita Neogi, AshutoshLal, Annie Higa et al. nutritional deficiencies are common in patients with transfusion dependent thalassemia and associated with iron overload. J of Food and Nutrition research 2018; 6(10):674-81
AnujaAdarsh, Asha Khubchandani, Disha Gajjar. Alteration in trace elements (s.iron, s.zinc, copper) in thalassemia major patients after chelation therapy. Int J Med Sci Educ. 2019; 6(1):63-5
Attakorn Palasuwan, Methee Sriprapun, Winai Dahlan, Rataya Luechapudiporn et al. Antioxidant protection in hemoglobin E trait subjects after vitamin E supplementation. Southeast Asian J Trop Med Public Health 2008;39(1):82-9
Attia MMA, Sayed AM, Mohammed FA, El-Alfy MA. Effect of Antioxidant Vitamins on Some Hemoglobin Properties and Erythrocytes in Homozygous Beta Thalassemia. Romanian J Biophys 2011;1(21):1-16
Ghone RA, Kumbar KM, Suryakar AN, Katkam RV, Joshi NG. Oxidative stress and disturbance in antioxidant balance in beta thalassemia major. Indian Journal of Clinical Biochemistry 2008;23(4):337-40
Shazia Q, Mohammad ZH, Taibur Rahman, Hossain Uddin Shekhar. Correlation of oxidative stress with serum trace elements levels and antioxidant enzyme status in beta thalassemia major patients: A review of the literature. Anemia 2012;2012:1-7
Elham Abed Mahdi. Relationship between oxidative stress and antioxidant status in beta thalassemia major patients. Acta Chim. Pharm. Indica: 2014;4(3):137-45
Varley H. Ramasaysdipyridyl method for iron. In: Practical clinical biochemistry 4th Ed. 1967: 472
Kajari Das. A modified spectrophotometric assay of superoxide dismutase using nitrate formation by superoxide radicals. Indian J of Biochem and Biophys 2000; 57: 201-4
Goth L. A simple method for determination of serum and erythrocyte catalase activity and the revision of the reference range. Clinica Chimica Acta 1991;196:143-5
Fatemeh B, Sedigheh S, Mahtab BE. Total antioxidant status in patients with major β-thalassemia. Iran J Pediatr 2011;21(2):159-65
Abolfazl M, Parviz A, Ali- Asghar P. Zinc and copper status in children with beta thalassemia major. Iran J Pediatr 2010;20(3):297-302
Thasinas Dissayabutra, Piyaratana T, Panya S. The benefits of vitamin C and vitamin E in children with β- thalassemia with high oxidative stress. J Med Assoc Thai 2005;88(4):317-21
Gerli GC, Berettz L, Bianchi M, Pellegatta A, Agostoni A. Erythrocyte superoxide dismutase, catalase and glutathione peroxidase activities in beta-thalassemia (major and minor). Scand J of Haematol 1980;25(1):87-92
Dibyendu C, Bhattacharyya M. Antioxidant defense status of red blood cells of patients with β- thalassemia and E β- thalassemia. Clinica Chimica Acta 2001;305(1):123-9